The aim is to examine the association of lifecourse socioeconomic position (SEP) on circulating levels of D-dimer. Data from the 1958 British birth cohort were used, social class was determined at three stages of respondents' life: at birth, at 23 and at 42 years. A cumulative indicator score of SEP (CIS) was calculated ranging from 0 (always in the highest social class) to 9 (always in the lowest social class). In men and women, associations were observed between CIS and D-dimer (P<0.05). Thus, the respondents in more disadvantaged social classes had elevated levels of D-dimer compared to respondents in less disadvantaged social class. In multivariate analyses, the association of disadvantaged social position with D-dimer was largely explained by fibrinogen, C-reactive protein and von Willebrand Factor in women, and additionally by smoking, alcohol consumption and physical activity in men. Socioeconomic circumstances across the lifecourse at various stages also contribute independently to raised levels of D-dimer in middle age in women only. Risk exposure related to SEP accumulates across life and contributes to raised levels of D-dimer. The association of haemostatic markers and social differences in health may be mediated by inflammatory and other markers.
References
[1]
Danesh J, Whincup P, Walker M, Lennon L, Thomson A, et al. (2001) Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation 15: 2323–7. doi: 10.1161/01.cir.103.19.2323
[2]
Lowe GD, Yarnell JW, Rumley A, Bainton D, Sweetnam PM (2001) C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis? Arterioscler Thromb Vasc Biol 21: 603–10. doi: 10.1161/01.atv.21.4.603
[3]
Lowe GD, Yarnell JW, Sweetnam PM, Rumley A, Thomas HF, et al. (1998) Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study. Thromb Haemost 79: 129–33. doi: 10.1097/00001721-199504000-00030
[4]
Lowe GD, Rumley A, McMahon AD, Ford I, O'Reilly DS, et al. (2004) Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arterioscler Thromb Vasc Biol 24: 1529–34. doi: 10.1161/01.atv.0000135995.39488.6c
[5]
Palareti G, Legnani C, Cosmi B, Valdre L, Lunghi B, et al. (2003) Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 108: 313–8. doi: 10.1161/01.cir.0000079162.69615.0f
[6]
Eichinger S, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, et al. (2003) D-dimer levels and risk of recurrent venous thromboembolism. JAMA 290: 1071–4. doi: 10.1001/jama.290.8.1071
[7]
Cosmi B, Palareti G (2005) D-dimer, oral anticoagulation, and venous thromboembolism recurrence. Semin Vasc Med 5: 365–70. doi: 10.1055/s-2005-922481
[8]
Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, et al. (2004) Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. J Clin Periodontol 31: 25–9. doi: 10.1111/j.0303-6979.2004.00432.x
[9]
Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, et al. (2005) Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease. J Clin Periodontol 32: 188–92. doi: 10.1111/j.1600-051x.2005.00641.x
[10]
Wannamethee SG, Whincup PH, Shaper AG, Rumley A, Lennon L, et al. (2009) Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Thromb Haemost 7: 1605–11. doi: 10.1111/j.1538-7836.2009.03574.x
[11]
Woodward M, Rumley A, Welsh P, MacMahon S, Lowe G (2007) A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease. J Thromb Haemost 5: 1795–800. doi: 10.1111/j.1538-7836.2007.02677.x
[12]
Smith A, Patterson C, Yarnell J, Rumley A, Ben-Shlomo Y, et al. (2005) Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation 112: 3080–7. doi: 10.1161/circulationaha.105.557132
[13]
Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, et al. (2006) Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol 26: 2793–9. doi: 10.1161/01.atv.0000249406.92992.0d
[14]
Quinn TJ, Gallacher J, Deary IJ, Lowe GD, Fenton C, et al. (2011) Association between circulating hemostatic measures and dementia or cognitive impairment: systematic review and meta-analyzes. J Thromb Haemost 9: 1475–82. doi: 10.1111/j.1538-7836.2011.04403.x
[15]
Carcaillon L, Gaussem P, Ducimetiere P, Giroud M, Ritchie K, et al. (2009) Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study. J Thromb Haemost 7: 1972–8. doi: 10.1111/j.1538-7836.2009.03603.x
[16]
Tabassum F, Kumari M, Rumley A, Lowe G, Power C, et al. (2008) Effects of socioeconomic position on inflammatory and hemostatic markers: a life-course analysis in the 1958 British birth cohort. Am J Epidemiol 167: 1332–41. doi: 10.1093/aje/kwn055
[17]
Kumari M, Marmot M, Brunner E (2000) Social determinants of von willebrand factor: the Whitehall II study. Arterioscler Thromb Vasc Biol 20: 1842–7. doi: 10.1161/01.atv.20.7.1842
[18]
Ramsay S, Lowe GD, Whincup PH, Rumley A, Morris RW, et al. (2008) Relationships of inflammatory and haemostatic markers with social class: results from a population-based study of older men. Atherosclerosis 197: 654–61. doi: 10.1016/j.atherosclerosis.2007.02.022
[19]
Ben Shlomo Y, Kuh D (2002) A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 31: 285–93. doi: 10.1093/ije/31.2.285
[20]
Blane D, Hart CL, Smith GD, Gillis CR, Hole DJ, et al. (1996) Association of cardiovascular disease risk factors with socioeconomic position during childhood and during adulthood. BMJ 313: 1434–8. doi: 10.1136/bmj.313.7070.1434
[21]
Kuh D, Smith GD (2004) The life course and adult chronic disease: an historical perspective with particular reference to coronary heart disease. In: Kuh D, Ben Shlomo Y, eds. A life course approach to chronic disease epidemiology. New York: Oxford University Press. p:15–41.
[22]
Hallqvist J, Lynch J, Bartley M, Lang T, Blane D (2004) Can we disentangle life course processes of accumulation, critical period and social mobility? An analysis of disadvantaged socio-economic positions and myocardial infarction in the Stockholm Heart Epidemiology Program. Soc Sci Med 58: 1555–62. doi: 10.1016/s0277-9536(03)00344-7
[23]
Power C, Atherton K, Strachan DP, Shepherd P, Fuller E, et al. (2007) Life-course influences on health in British adults: effects of socio-economic position in childhood and adulthood. Int J Epidemiol 36: 532–9. doi: 10.1093/ije/dyl310
[24]
Atherton K, Fuller E, Shepherd P, Strachan DP, Power C (2008) Loss and representativeness in a biomedical survey at age 45 years: 1958 British birth cohort. J Epidemiol Community Health 62: 216–23. doi: 10.1136/jech.2006.058966
[25]
Rudnicka AR, Rumley A, Lowe GD, Strachan DP (2007) Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 115: 996–1003. doi: 10.1161/circulationaha.106.635169
[26]
Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837–47. doi: 10.1161/01.cir.97.18.1837
[27]
Brunner E, Davey SG, Marmot M, Canner R, Beksinska M, et al. (1996) Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet 347: 1008–13. doi: 10.1016/s0140-6736(96)90147-6
[28]
Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T (2003) Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epidemiol Community Health 57: 730–3. doi: 10.1136/jech.57.9.730
[29]
Koster A, Bosma H, Penninx BW, Newman AB, Harris TB, et al. (2006) Association of inflammatory markers with socioeconomic status. J Gerontol A Biol Sci Med Sci 61: 284–90.
[30]
Zoller B, Li X, Sundquist J, Sundquist K (2012) Socioeconomic and occupational risk factors for venous thromboembolism in Sweden: A nationwide epidemiological study. Thromb Res 129: 577–82. doi: 10.1016/j.thromres.2011.07.050
[31]
Rosengren A, Wilhelmsen L, Welin L, Tsipogianni A, Teger-Nilsson AC, et al. (1990) Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. BMJ 300: 634–8. doi: 10.1136/bmj.300.6725.634
[32]
Pieper CF, Rao KM, Currie MS, Harris TB, Cohen HJ (2000) Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons. J Gerontol A Biol Sci Med Sci 55: M649–M657. doi: 10.1093/gerona/55.11.m649
[33]
Yarnell JWG, Sweetnam PM, Rumley A, Lowe GDO (2000) Lifestyle and Hemostatic Risk Factors for Ischemic Heart Disease: The Caerphilly Study. Arteriosclerosis, Thrombosis, and Vascular Biology 20: 271–9. doi: 10.1161/01.atv.20.1.271
